12 December 1997
Ann Transplant 1997; 2(4): 67-69 :: ID: 497345
Since the first associations between de novo cancer and immunosuppression in renal allograft recipients were reported by Doak , Starzl  and Zukoski  in 1968, it has become increasingly clear that organ transplant patients are at increased risk for development of malignancy. However, the pattern of cancer incidence in transplant recipients is distinctly different from that in the general population, with a marked excess in the occurrence of carcinoma of the skin and lips, non-Hodgkin's lymphoma (NHL)...
Keywords: transplant, cancer, PTLD
11 Jan 2022 : Original articleEfficacy of Nitric Oxide-Releasing Nanofibers in Reducing Renal Ischemia-Reperfusion Injury in a Rat Model
Ann Transplant In Press; DOI: 10.12659/AOT.934800
Most Viewed Current Articles
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
22 Dec 2021 : Original articleComparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery ...
Ann Transplant 2021; 26:e934163
01 Dec 2021 : Original articleSolid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-S...
Ann Transplant 2021; 26:e934175